Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by ELS Solutions Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ELS Solutions Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Integration of Artificial Intelligence in Pharmacovigilance. Transforming Drug Safety

10:00
 
Share
 

Manage episode 495215264 series 3382167
Content provided by ELS Solutions Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ELS Solutions Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Artificial Intelligence is Reshaping Pharmacovigilance – But Are You Ready?

With over 1.5 million adverse drug reactions reported annually in the EU alone, the pressure on pharmacovigilance systems has never been greater. Could artificial intelligence (AI) be the answer?

In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins, Founder and President of ELS Group, discusses how AI is transforming the landscape of drug safety, and what pharmaceutical companies must do to stay ahead.

From automation and real-time signal detection to regulatory hurdles and ethical challenges, we break down how AI is redefining the future of pharmacovigilance and what that means for compliance, patient safety, and innovation.

You’ll learn more about:

  • How AI enhances adverse event detection across large, unstructured data sources

  • Compliance requirements under EMA, FDA, and ISO standards

  • Why early-stage integration of AI is a strategic (not optional) investment

  • How companies can adopt scalable, cost-effective AI solutions without compromising compliance

The integration of AI into pharmacovigilance isn’t a distant possibility, it’s an urgent priority. But real transformation requires more than just algorithms. It demands strategic planning, regulatory alignment, and expert guidance.

Tune in now to understand how your company can use AI to enhance pharmacovigilance performance, reduce risk, and strengthen patient trust.

Learn more at els-solutions.com/This episode was recorded in 2025. Some of the data discussed may have changed since then. This podcast has been prepared using various bibliographic sources. The opinions expressed reflect the professional experiences of ELS members and referenced material.

  continue reading

41 episodes

Artwork
iconShare
 
Manage episode 495215264 series 3382167
Content provided by ELS Solutions Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ELS Solutions Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Artificial Intelligence is Reshaping Pharmacovigilance – But Are You Ready?

With over 1.5 million adverse drug reactions reported annually in the EU alone, the pressure on pharmacovigilance systems has never been greater. Could artificial intelligence (AI) be the answer?

In this episode of International Pharma Talks, Dr. Diogo Sousa-Martins, Founder and President of ELS Group, discusses how AI is transforming the landscape of drug safety, and what pharmaceutical companies must do to stay ahead.

From automation and real-time signal detection to regulatory hurdles and ethical challenges, we break down how AI is redefining the future of pharmacovigilance and what that means for compliance, patient safety, and innovation.

You’ll learn more about:

  • How AI enhances adverse event detection across large, unstructured data sources

  • Compliance requirements under EMA, FDA, and ISO standards

  • Why early-stage integration of AI is a strategic (not optional) investment

  • How companies can adopt scalable, cost-effective AI solutions without compromising compliance

The integration of AI into pharmacovigilance isn’t a distant possibility, it’s an urgent priority. But real transformation requires more than just algorithms. It demands strategic planning, regulatory alignment, and expert guidance.

Tune in now to understand how your company can use AI to enhance pharmacovigilance performance, reduce risk, and strengthen patient trust.

Learn more at els-solutions.com/This episode was recorded in 2025. Some of the data discussed may have changed since then. This podcast has been prepared using various bibliographic sources. The opinions expressed reflect the professional experiences of ELS members and referenced material.

  continue reading

41 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play